FDA-cleared AI-CVD® extracts preventive insights from routine CT—identifying hidden cardiovascular, metabolic, and ...

"Variations in the use of secondary CVD prevention medications over time in our contemporary cohort study suggest little to no improvement globally." HealthDay News — Use of secondary cardiovascular ...

An annual report from the American Heart Association shows deaths from heart disease and stroke are down, encouraging news after the rate went up in the early years of the pandemic.

Please provide your email address to receive an email when new articles are posted on . A polypill-based strategy may be cost-effective for primary CVD prevention in historically underserved ...

Broader uptake of single-pill combination (SPC) therapies—polypills—to simplify primary or secondary prevention of cardiovascular disease could have a huge impact on a global scale in the coming ...

Across the world, many patients with CVD still aren’t on the recommended medications for secondary prevention, according to more than a decade’s worth of data from the 17-country Prospective Urban ...

Deaths have fallen, but cardiovascular disease still leads U.S. mortality, with daily habits playing a key role in risk.

Boston, MA - A new study demonstrates that providing a multidrug regimen of aspirin, two blood-pressure drugs, and a statin in the developing world is affordable and could have the profound effect of ...

The rate of heart disease-related deaths declined from 2022 to 2023, but cardiovascular disease remains the leading cause of ...

Deaths from heart disease and stroke are declining, but still kill more Americans than any other cause, according to new data ...

Veena Raleigh examines the role of cardiovascular disease in the health of Europeans, proposals for alleviating it, and ...